Janalee Taylor

ORCID: 0000-0003-0132-8254
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Autoimmune and Inflammatory Disorders Research
  • Adolescent and Pediatric Healthcare
  • Childhood Cancer Survivors' Quality of Life
  • Kawasaki Disease and Coronary Complications
  • Acute Lymphoblastic Leukemia research
  • Systemic Lupus Erythematosus Research
  • Inflammasome and immune disorders
  • Rheumatoid Arthritis Research and Therapies
  • Family and Disability Support Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Ocular Diseases and Behçet’s Syndrome
  • Urticaria and Related Conditions
  • Renal Diseases and Glomerulopathies
  • Immunodeficiency and Autoimmune Disorders
  • Diabetes and associated disorders
  • Romani and Gypsy Studies
  • Sports injuries and prevention
  • Migration, Health and Trauma
  • COVID-19 and healthcare impacts
  • Sex and Gender in Healthcare
  • Telemedicine and Telehealth Implementation
  • Child and Adolescent Health
  • Ethics and Legal Issues in Pediatric Healthcare
  • Celiac Disease Research and Management
  • Healthcare Systems and Technology

Connecticut Children's Medical Center
2024

Cincinnati Children's Hospital Medical Center
2011-2023

Amgen (United States)
2021

City, University of London
2020

University of Cincinnati
1990-2018

Center for Rheumatology
2011

Boston Children's Hospital
1999

University of Cincinnati Medical Center
1992

Indiana University School of Medicine
1987

Indiana University
1987

Objective. In a cohort of 70 patients with childhood-onset systemic lupus erythematosus (cSLE): to determine the baseline adherence medications and visits; investigate effects cellular text messaging reminders (CTMR) on clinic study influence CTMR use hydroxychloroquine (HCQ). Methods. were sent prior visits for 14 months. A subgroup evaluated medication HCQ: 19 receiving each scheduled HCQ dose compared 22 randomized standard care education about HCQ. Visit was measured using administrative...

10.3899/jrheum.110771 article EN The Journal of Rheumatology 2011-11-15

To design, implement, and assess the impact of an office-based intervention designed to improve rheumatologists' identification risk behaviors, especially alcohol use sexual activity, among adolescents young adults with chronic rheumatologic conditions.Prospective study.Midwestern academic pediatric rheumatology practice.Ten attending rheumatologists fellows 178 patients (mean age, 18.1 years; 67% female; 88% white; 69% juvenile rheumatoid arthritis) seen in practice during baseline...

10.1001/archpedi.154.5.478 article EN Archives of Pediatrics and Adolescent Medicine 2000-05-01

Objective To investigate the hypothesis that children with juvenile rheumatoid arthritis (JRA) would have more social and emotional problems than case–control classmates. Methods Using a design, JRA (n = 74), ages 8–14, were compared classmates 74). Peer relationships, well-being, behavior, based on peer-, teacher-, parent-, self-report scores common measures, using analysis of variance. Results Relative to classmates, similar all measures functioning behavior. Mothers reported internalizing...

10.1002/1529-0131(200006)43:6<1387::aid-anr24>3.0.co;2-c article EN Arthritis & Rheumatism 2000-06-01

On the basis of surname, 6418 Asians were identified out a total 109 187 deaths and discharges Leicestershire residents who had been treated in hospitals Trent Regional Health Authority over two years. After linkage to Hospital Activity Analysis computerised records, hospital morbidity non-Asians was compared. Asian patients certain age groups more likely than non-Asian be diagnosed as having asthma; leukaemia; diabetes mellitus; blood, thyroid, eye disorders; forms heart disease;...

10.1136/bmj.286.6369.949 article EN BMJ 1983-03-19

Objective To determine the relationship between serum levels of S100A8/A9 and S100A12 maintenance clinically inactive disease during anti–tumor necrosis factor (anti‐ TNF ) therapy occurrence flare following withdrawal anti‐ in patients with polyarticular forms juvenile idiopathic arthritis (JIA). Methods In this prospective, multicenter study, 137 polyarticular‐course JIA whose was while receiving were enrolled. Patients observed for an initial 6‐month phase which treatment continued. For...

10.1002/art.40727 article EN Arthritis & Rheumatology 2018-09-18
Daniel J. Lovell Nikolay Tzaribachev Michael Henrickson Gabriele Simonini Thomas A. Griffin and 95 more Е.I. Alexeeva John F. Bohnsack Andrew Zeft Gerd Horneff Richard K. Vehe Valda Staņēviča Stacey E. Tarvin Maria Trachana Ana Quintero del Río Adam M. Huber Daniel Kietz Ilonka Orbán Jason Dare Ivan Foeldvari Pierre Quartier Alyssa Dominique Teresa A. Simon Alberto Martini Hermine I. Brunner Nicolino Ruperto Jürgen Brunner Taciana de Albuquerque Pedrosa Fernandes Simone Appenzeller Sheila Oliveira Maria Teresa Terreri Nikolay Tzaribachev Kirsten Minden Mark Hufnagel Ivan Foeldvari Gerd Horneff Astrid Helling-Bakki Troels Herlin E. Moreno Jordi Antón Pablo Mesa- del-Castillo Clara Udaondo Inmaculada Calvo Penadés Pierre Quartier Karine Brochard Athimalaipet V Ramanan Maria Trachana Ilonka Orbán Philip J. Hashkes Nicolino Ruperto Gabriele Simonini Alma Nunzia Olivieri Francesco Zulian Davide Montin Diego Peroni Valda Staņēvicha Gabriel Vega‐Cornejo Nico Wulffraat Sylvia Kamphuis Maria Eliana Paz Gastañaga Tatiana Miraval Filipa Oliveira‐Ramos Călin Lazăr И. П. Никишина Е.I. Alexeeva Aleksej Sarychev Vyacheslav Chasnyk Lyudmila Grebenkina Wafaa Mohammed Saad Suwairi E Košková Mahmood M. T. M. Ally Ingrid Louw Johannes Breedt Hermine I. Brunner Tracy V. Ting Janalee Taylor Jennifer Huggins Michael Henrickson Esi Morgan DeWitt Alexei A. Grom Daniel J. Lovell Grant S. Schulert Jackeline Rodriguez‐Smith Jason Dare Paula Morris Sukesh Sukumarain M Klein Gitelman Michael Miller Megan L. Curran Risa Alperin Kaveh Ardalan Deirdre De Ranieri M. Hiskey Brian Nolan Beth Chalom Andy Zelf Steven J. Spalding D. Costanzo Robert M. Rennebohm Brenda Waugaman Elizabeth Brodus

Abstract Objective The aim of this study was to report the interim 5-year safety and effectiveness abatacept in patients with JIA PRINTO/PRCSG registry. Methods Abatacept Registry (NCT01357668) is an ongoing observational children receiving abatacept; enrolment started January 2013. Clinical sites enrolled starting or currently abatacept. Eligible were assessed for (primary end point) over 10 years. Effectiveness measured by clinical 10-joint Juvenile Arthritis Disease Activity Score...

10.1093/rheumatology/keae025 article EN cc-by-nc Lara D. Veeken 2024-01-18

The ability to assess quality of care is a necessary component continuous improvement. assessment typically accomplished by determination compliance with defined set measures (QMs). objective this effort was establish QMs for the process in juvenile idiopathic arthritis (JIA).A 12-member working group composed representatives from American College Rheumatology, Academy Pediatrics, Board and Association Rheumatology Health Professionals assembled guide project. Delphi questionnaires were sent...

10.1002/acr.20348 article EN Arthritis Care & Research 2010-09-14

Objective. Nonadherence is currently an underrecognized and potentially modifiable obstacle to care in juvenile idiopathic arthritis (JIA). The purpose of our study was design implement a standardized approach identifying adherence barriers for youth with JIA across 7 pediatric rheumatology clinics through the Pediatric Rheumatology Care Outcomes Improvement Network (PR-COIN) assess frequency patients their caregivers treatment modalities. Methods. An iterative process using coproduction...

10.3899/jrheum.171087 article EN The Journal of Rheumatology 2018-02-01

Randomized trials have demonstrated the efficacy of patient decision aids to facilitate shared making in clinical situations with multiple medically reasonable options for treatment. However, little is known about how best implement these tools into routine practice. In addition, reliable implementation has been elusive and spread within pediatrics slow. We sought develop reliably a aid treatment children juvenile idiopathic arthritis. To design our aid, we partnered patient, parent,...

10.1186/s12969-017-0177-x article EN cc-by Pediatric Rheumatology 2017-06-05

To describe the selection, development, and implementation of quality measures (QMs) for juvenile idiopathic arthritis (JIA) by Pediatric Rheumatology Care Outcomes Improvement Network (PR-COIN), a multihospital learning health network using improvement methods leveraging QMs to drive improved outcomes across JIA population since 2011.An American College Rheumatology-endorsed multistakeholder process previously selected initial QMs. Clinicians in PR-COIN parents children with collaboratively...

10.1002/acr.25168 article EN cc-by-nc-nd Arthritis Care & Research 2023-06-12

Abstract Objective To determine the relationship between health insurance status and disease outcome in children with juvenile rheumatoid arthritis (JRA). Methods JRA patients followed at a tertiary pediatric rheumatology center were assessed for number of active joints limited range motion. Disease activity, patient well‐being, pain measured. Disability was by Childhood Health Assessment Questionnaire, health‐related quality life Pediatric Quality Life Inventory (PedsQL) Generic Core Scale,...

10.1002/art.21991 article EN Arthritis Care & Research 2006-05-31

Objective To determine the frequency, time to flare, and predictors of disease flare upon withdrawal anti–tumor necrosis factor (anti‐ TNF ) therapy in children with polyarticular forms juvenile idiopathic arthritis ( JIA who demonstrated ≥6 months continuous clinically inactive disease. Methods In 16 centers 137 patients were receiving anti‐ (42% whom also methotrexate [ MTX ]) prospectively followed up. If remained for initial 6 study, was stopped assessed at 1, 2, 3, 4, 6, 8 months....

10.1002/art.40509 article EN Arthritis & Rheumatology 2018-03-31

Objective Treat to target (T2T) is a strategy of adjusting treatment until reached. An international task force recommended T2T for juvenile idiopathic arthritis (JIA) treatment. Implementing in standard and reliable way clinical practice requires agreement on critical elements (1) setting, (2) strategy, (3) identifying barriers implementation, (4) patient eligibility. A consensus conference was held among Pediatric Rheumatology Care Outcomes Improvement Network (PR-COIN) stakeholders inform...

10.3899/jrheum.210709 article EN The Journal of Rheumatology 2022-02-01

Healthcare providers were rapidly forced to modify the way they practiced medicine during coronavirus disease 2019 (COVID-19) pandemic. Many transitioned from seeing their patients in person virtually using telemedicine platforms with limited training and experience this medium. In pediatric rheumatology, was further complicated as musculoskeletal exams typically require hands-on assessment of patients. The objective study examine adoption into rheumatology practices, assess its benefits...

10.3389/fped.2021.642460 article EN cc-by Frontiers in Pediatrics 2021-03-04

Abstract Objective To examine educational and occupational outcomes among young adults with juvenile idiopathic arthritis (JIA) peers during the transition from adolescence to emerging adulthood. Methods Families were recruited when children JIA 8–14 years old. At that time, each child was matched a classmate of similar age, sex, race for inclusion in comparison group. For current followup (12.64 postdiagnosis), 45 participants JIA, 46 peers, their parents completed questionnaires soon after...

10.1002/art.24100 article EN Arthritis Care & Research 2008-09-29

To determine the frequency of laboratory abnormalities with methotrexate (MTX) use in patients juvenile idiopathic arthritis (JIA); to identify potential risk factors for MTX toxicity requiring medical interventions; and compare liver function treated those not MTX.Results surveillance testing (SLT) available clinical databases were reviewed 588 children JIA. Information on demographics, JIA features, previously associated increased SLT was obtained.Results performed at least 4-month...

10.3899/jrheum.090482 article EN The Journal of Rheumatology 2009-11-16

Objective To measure agreement among raters when scoring the physician/provider global assessment (PGA) of disease activity in patients with juvenile idiopathic arthritis (JIA) no apparent activity, and to identify clinical laboratory parameters that most strongly influence provider PGA. Methods Profiles findings from 20 JIA were given 51 providers, who asked score PGA using a 21‐circle visual analog scale (range 0–10). Following initial scoring, providers discussed each profile reasons for...

10.1002/acr.23203 article EN Arthritis Care & Research 2017-01-24

Background/Purpose: Medication options for juvenile idiopathic arthritis (JIA) are increasing. Medications differ on a variety of attributes, including mechanisms action, dosing intervals, modes administration, safety profiles, and cost. Some parents children with JIA left questions concerns about medications suggesting need improved clinician‐parent communication. Decisions like this, multiple reasonable that in ways matter to families, conducive “Shared Decision Making” (SDM). SDM is...

10.1002/art.38604 article EN Arthritis & Rheumatology 2014-03-01

ABSTRACT: Juvenile rheumatoid arthritis (JRA) may cause a variety of school problems. Twenty‐four children with JRA, 24 their parents, and 14 teachers completed questionnaires regarding the frequency 40 potential problems extent teacher's responsibility in helping deal 28 medical, academic, or social issues. Though respondents viewed as occurring infrequently, parents more frequently than noted that occurred (p &lt; .05). Children felt self‐concept peer relationships most frequently, while...

10.1111/j.1746-1561.1987.tb00536.x article EN Journal of School Health 1987-05-01

Initial benchmarking of childhood-onset systemic lupus erythematosus (cSLE) quality indicators revealed suboptimal performance across multiple centers. Our aim was to improve cardiovascular and bone health screenings at a tertiary treatment center for cSLE. This included annual measurements vitamin D, lipid profiles, mineral density through dual-energy x-ray absorptiometry (DXA).Quality improvement methodology applied design implement standardized previsit planning process electronically...

10.3899/jrheum.190295 article EN The Journal of Rheumatology 2019-09-01
Coming Soon ...